5 Small-Cap Stocks with High Potential

4. Immatics N.V. (NASDAQ:IMTX)

Number of Hedge Fund Holders: 33

Market Capitalization: $908 million

Tuebingen, Germany-based Immatics N.V. (NASDAQ:IMTX) is a clinical-stage biopharmaceutical company active in the discovery and development of T cell-redirecting cancer immunotherapies.

On September 11, Immatics N.V. (NASDAQ:IMTX) and Moderna, Inc. (NASDAQ:MRNA) announced a strategic research and development collaboration to develop breakthrough, mRNA-enabled in vivo expressed TCER® molecules.

As part of the agreement, Immatics N.V. (NASDAQ:IMTX) will receive an upfront payment of $120 million. The company will also receive research funding and is eligible to receive development, regulatory, and commercial milestone payments that could exceed $1.7 billion.

As of Q3 2023, Immatics N.V. (NASDAQ:IMTX) shares were held by 33 leading hedge funds tracked by Insider Monkey with the total shares held by hedge funds valued at $280 million. Baker Bros. Advisors was its leading hedge fund shareholder with ownership of 5.6 million shares valued at $65 million.